Study found that exoglycosidases from Akkermansia muciniphila effectively target blood group antigens, potentially converting A and B blood types to ABO-universal blood.
Menu
Dr. Steve Miff, President and CEO of Parkland Center for Clinical Innovation (PCCI) Artificial intelligence (AI) is making a tangible difference in healthcare today. It’s
According to GlobalData’s company profile on Vertex Pharmaceuticals, Human telomerase RT biomarker was a key innovation area identified from patents. Vertex Pharmaceuticals‘s grant share as